New search | Conferencedetail
mail
Print view
 
 

2nd ALS Drug Development Summit

Evvnt Promotion / evvnt
-
16.05.2023 - 18.05.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
9:00 am - 4:30 pm
 
Conference themes
Following the approval of Amylyx's Relyvrio in the US and Canada and further FDA decisions on the horizon in 2023, the ALS drug development landscape is gaining momentum and positivity. With booming pharma investment and new biotechs entering the field, there are still crucial translational challenges to address to bridge the gap and see clinical success for the wider ALS patient population.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/1485150-3?pid=4832

Speakers: Alain Moussy, Co-Founder and Chief Executive Officer, AB Science, and more.
 

Enquiries and Registration:

https://go.evvnt.com/1485150-2?pid=4832
Ms. Erin Thomas
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5297.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHilfswerk AustriaÄrztekammer für WienCenter of ExcellenceÄrzte der WeltEuropean Health Forum GasteinÖsterreichisches Rotes Kreuz